Furthermore, the KEGG pathway analysis suggested that these ETGs might play a role in controlling the EMT process via the MAPK signaling pathway and could potentially be linked to the resistance of EGFR tyrosine kinase inhibitors in the BC treatment (Figure 2B; Supplementary Table 4). Here, EGFR is linked to breast cancer.